Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by Butantan Institute
Sponsor:
Collaborators:
Banco Nacional de Desenvolvimento Economico e Social
Fundação de Amparo à Pesquisa do Estado de São Paulo
Butantan Foundation
Information provided by (Responsible Party):
Butantan Institute
ClinicalTrials.gov Identifier:
NCT01696422
First received: September 27, 2012
Last updated: October 8, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)